HNRNPH1 and chronic myelogenous leukemia, BCR-ABL1 positive: Both in vivo and in vitro studies have indicated that silencing HNRNPH1 hinders cell proliferation and enhances apoptosis in Chronic Myeloid Leukemia cells [38].